Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Esophageal Diseases × Radiation × Clear all

Phase

Status

Sponsor Class

OTHER_GOV 1 OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Neoplasms 4 Breast Neoplasms 3 Neoplasm Metastasis 2 Nasopharyngeal Carcinoma 2 Recurrence 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Lung Neoplasms 1 Fatigue 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Diseases 1 Digestive System Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

camrelizumab 1 Radiation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05624099 2023-10-19

Camrelizumab Combined With Chemoradiotherapy in Advanced Esophageal Cancer.

Fujian Cancer Hospital

Phase 2 Recruiting

Gastrointestinal

Digestive System Neoplasms, Esophageal Diseases, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡